WHO WE ARE

​

Caroline Derne is managing Clinical Studies since 2002, covering scientific and operational activities.

She holds a Master Degree in Health Engineering, specialized in Drug Development, from the Pharmacy Faculty of Montpellier, France.

She has experience in several therapeutic areas in Phase I, II, III and in paediatric development. She defines herself as empathic, communicative, and problem solver.

 

Caroline started her career in Contract Research Organizations as a Clinical Research Associate, responsible for setting up and monitoring clinical sites in France, Belgium and Italy, for major pharmaceutical companies. She moved to Study Management positions in Oncology at Bristol-Myers Squibb, where she set up and led phase 1 to phase 3 trial over France and South Africa. Then she evolved through global positions at Novartis Pharma A.G, in Oncology and Translational Medicine. As a Senior Clinical Scientist at Actelion, she coordinated the scientific set up of the Paediatric Studies program. Subsequently she worked for Amzell B.V, a small virtual company at the time, to move forward the pipeline in clinical phase. 
Caroline believes in science; she enjoys working in collaborative teams and projectized environment. 

​

 

CDBMCo was founded in 2022 aiming to provide Pharmaceutical Companies with clinical trial expertise and foster success in their projects.

​

​

Our objectives: robust Clinical data through the following 3 pillars:

• Structured Project Management & Communication

• Team Collaboration

• Well-written Clinical Protocols 

Our values:

• Ethics standards compliance

• Trustful partnering

• Do it right the first time